Coronary Artery Disease Clinical Trial
Official title:
Individuell Dosiertes Kraft-ausdauer-training in Ambulanten Herzgruppen - Einfluss Auf Koerperliche Belastbarkeit Von Herzpatienten.
Seventy patients in cardiac rehabilitation with maximal exercise capacity less than 1.4 watt per kilogram bodyweight will be randomized 1:1 into either an intervention training (IN) group or usual care (UC). The IN patients will perform supervised endurance and resistance exercise for approximately 90 minutes once a week and traditional cardiac rehabilitation (TCR) once a week; the UC patients will perform TCR twice a week. The intervention is planned for six months with a follow-up of a further six months. The primary investigation is differences between IN and UC with regard to changes in exercise capacity (max watt/kgBW).
The DOPPELHERZ (The influence of individualized resistance-endurance exercise training on
maximal power output in outpatient cardiac rehabilitation) randomized controlled trial was
performed at the Department of Prevention and Sports Medicine, Klinikum rechts der Isar in
Munich, Germany. 70 patients eligible for and/or participating in cardiac rehabilitation
were randomized to six months in an individualized combined exercise group (ICE) or group-
based cardiac rehabilitation (GCR), considered usual care in this patient population.
All patients gave written informed consent, the study protocol was approved by the local
university hospital ethics committee, all procedures were conducted according to the
Declaration of Helsinki.
Participants: All patients were American Heart Association Class "C" (moderate to high risk)
based on the presence of cardiac disease and maximal power output of <5 METs (corresponding
to <1.4 W/kg body weight), who met eligibility criteria for CR at the time of recruitment.
Patients with decompensated or highly symptomatic (NYHA IV) heart failure, acute illness or
injury, cardiac hospitalizations within six weeks of inclusion, drug abuse, unstable blood
pressure or arrhythmias, high grade valve stenosis or instable diabetes mellitus were
excluded.
Primary endpoint: The primary endpoint was change in maximal relative power output (W/kg)
measured by CPX after six months.
Exercise training program In both the intervention and usual care arms of the study,
exercise training was prescribed twice weekly over a period of six months, and all exercise
sessions were led by certified exercise instructors and monitored by physicians.
Group-based cardiac rehabilitation (GCR): The GCR group performed regular exercise in a
state-sanctioned cardiac rehabilitation group. This form of GCR is considered Phase III
aftercare and has been described elsewhere9. Briefly, GCR patients received
moderate-intensity heart rate targets from exercise cardiologists based on CPX results. The
group-based program is offered for 90 minutes twice a week and is a combination of
gymnastics (including endurance and resistance components), coordination and flexibility
exercises, and includes educational components targeting diet and nutrition, stress and
relaxation, methods for coping with CVD and behavioral and lifestyle change. The GCR
sessions were conducted at a local university gymnasium and were performed in groups of up
to 15 participants, as recommended by the German Federal Association for Rehabilitation.
Individualized combined exercise (ICE): The ICE group participated in once-weekly
individualized combined resistance-endurance exercise training for 60 minutes and
once-weekly traditional group-based cardiac rehabilitation as described above. The ICE
intervention included 30 minutes of endurance exercise at 60-70% VO2peak and RPE 11-14 and
five resistance exercises (chest press, leg press, lat pull-downs, shoulder press and seated
cable row) following the recommendations of the German Federation for Cardiovascular
Prevention and Rehabilitation (DGPR) and targeting the large muscle groups at an RPE<16. For
the first three months, patients performed two sets of 12-25 repetitions at 30-50% 1RM;
after three months patients were retested and thereafter performed two sets of 8-15
repetitions at 40-60% 1RM. The ICE sessions were located at the university sports medicine
rehabilitation center and performed in groups of not more than four patients. They were
instructed at a maximum 2:1 participant to therapist ratio.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
| Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
| Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
| Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
| Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
| Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
| Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
| Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
| Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
| Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
| Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
| Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
| Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
| Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
| Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |